| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 170729-80-3 | 阿瑞吡坦; 阿瑞匹坦; 5-[2(R)-[1(R)-[3,5-二(三氟甲基)苯基]乙氧基]-3(S)-(4-氟苯基)嗎啉-4-基甲基]-3,4-二氫 | AprEpitant; 5-[2(R)-[1(R)-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)morpholin-4-ylmethyl]-3,4-dihydro-2H-1,2,4-triazol-3-one |  | C23H21F7N4O3 | 詳情 | 供應(yīng)商 |
| 172673-20-0 | 福沙吡坦; [3-[[(2R,3S)-2-[(1R)-1-[3,5-雙(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)-4-嗎啉基]甲基]-2,5-二氫-5 | FosaprEpitant; [3-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonic acid |  | C23H22F7N4O6P | 詳情 | 供應(yīng)商 |
| 307297-39-8 | Glycine, L-alanyl-L-a-glutamyl-L-a-aspartyl-; 10:PN: WO02090380 PAGE: 55 claimed protein; 121: PN: WO2009120968 SEQID: 121claimed protein; 125: PN: US20080268015 SEQID: 125 claimed protein; 125: PN:WO2008134329 SEQID: 125 claimed protein; 141: PN: US20080015138 SEQID: 96unclaimed sequence; 2: PN: US20080182894 SEQID: 2 claimed protein; 4: PN:WO02090380 PAGE: 55 claimed protein; 9: PN: WO02090380 PAGE: 55 claimedprotein; Epitalon; Epithalon |  | C14H22N4O9 | 詳情 | 供應(yīng)商 | |
| 38989-99-0 | Sarpagan-21-ol,17,19-epoxy-19,20-dihydro-1-methyl-, (19S,20b,21b)- (9CI); 8,1,5-Ethanylylidene-4H-[1,5]oxazocino[5',4':1,6]pyrido[3,4-b]indole,sarpagan-21-ol deriv.; 21-Epitalpinin; 21-Epitalpinine; Epitalpinine |  | C20H24N2O2 | 詳情 | 供應(yīng)商 | |
| 2299-26-5 | Vobasan-17-oic acid,19,20-dihydro-3-oxo-, methyl ester, (20a)-; Dregamine(6CI,8CI); 2,6-Methano-1H-azecino[5,4-b]indole, vobasan-17-oic acid deriv.; (-)-Dregamine; 20-Epitabernemontanine; NSC 177392 |  | C21H26N2O3 | 詳情 | 供應(yīng)商 | |
| 419574-04-2 | 3-Morpholinone,6-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-5-(4-fluorophenyl)-, (5S,6R)-; (5S,6R)-6-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-5-(4-fluorophenyl)-3-morpholinone[AprEpitant-M3]; AprEpitant-M3 Metabolite |  | C20H16F7NO3 | 詳情 | 供應(yīng)商 | |
| 20460-33-7 | 27-Norolean-14-en-3-ol,13-methyl-, (3a,13a)-; D-Friedoolean-14-en-3-ol,(3a)-; D-Friedoolean-14-en-3a-ol (8CI); 3-Epitaraxerol; 3-Picenol, 1,2,3,4,4a,5,6,6a,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-eicosahydro-4,4,6a,8a,11,11,12b,14b-octamethyl-,[3R-(3a,4aa,6ab,8ab,12ab,12ba,14aa,14bb)]-; 3a-Taraxerol; Epitaraxerol; Isotaraxerol |  | C30H51O | 詳情 | 供應(yīng)商 | |
| 153381-68-1 | 7-表多西他賽 | 7-Epi-docetaxel (Docetaxel Impurity C); (2b,5b,7a,10b,13a)-4-Acetoxy-13-(((2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl)oxy)-1,7,10-trihydroxy- 9-oxo-5,20-epoxytax-11-en-2-yl Benzoate; 7-Epidocetaxel; 7-Epi-docetaxel (Docetaxel Impurity C); 7-Epitaxotere; Docetaxel Impurity C | 無 | C43H53NO14 | 詳情 | 供應(yīng)商 |
| 105454-04-4 | 7-表紫杉醇 | 7-Epitaxol; Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (2ar,4R,4as,6R,9S,11S,12S,12ar,12bs)-6,12B-bis(acetyloxy)-12-(benzoyloxy)- 2A,3,4,4A,5,6,9,10,11,12,12A,12B-dodecahydro-4,11-dihydroxy-4A,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-B)oxet-9-yl ester, (alphar,betas)-; Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12B-bis(acetyloxy)-12-(benzoyloxy)-2A,3,4,4A,5,6,9,10,11,12,12A,12B-dodecahydro-4,11-dihydroxy-4A,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-B)oxet-9-yl ester, (2ar- (2aalpha,4alpha,4abeta,6beta,9alpha(alphar*,betas*),11alpha,12alpha,12aalpha,12balpha))-; Epitaxol |  | C47H51NO14 | 詳情 | 供應(yīng)商 |